• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19.新型冠状病毒肺炎确诊患者中新型冠状病毒2型的眼部症状及嗜性评估。
Acta Ophthalmol. 2020 Aug;98(5):e649-e655. doi: 10.1111/aos.14445. Epub 2020 Apr 26.
2
Dry eye symptoms are prevalent in moderate-severe COVID-19, while SARS-COV-2 presence is higher in mild COVID-19: Possible ocular transmission risk of COVID-19.干眼症症状在中重度新冠肺炎患者中普遍存在,而轻度新冠肺炎患者中新型冠状病毒的存在率更高:新冠肺炎可能存在眼部传播风险。
Heliyon. 2024 Mar 27;10(7):e28649. doi: 10.1016/j.heliyon.2024.e28649. eCollection 2024 Apr 15.
3
The Characteristics of Ocular Findings and the Presence of SARS-CoV-2 in the Tears of Coronavirus Disease 2019 Patients.2019冠状病毒病患者泪液中的眼部表现特征及严重急性呼吸综合征冠状病毒2型的存在情况
Cureus. 2023 Sep 2;15(9):e44589. doi: 10.7759/cureus.44589. eCollection 2023 Sep.
4
Ocular transmission and manifestation for coronavirus disease: a systematic review.眼部传播与冠状病毒病表现:系统综述。
Int Health. 2022 Mar 2;14(2):113-121. doi: 10.1093/inthealth/ihab028.
5
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.中国湖北省 2019 年冠状病毒病(COVID-19)患者的眼部表现特征。
JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.
6
[Ocular symptoms in SARS-CoV-2 infection].[严重急性呼吸综合征冠状病毒2型感染中的眼部症状]
Pol Merkur Lekarski. 2022 Apr 19;50(296):86-93.
7
SARS-CoV-2 in Conjunctiva and Tears and Ocular Symptoms of Patients with COVID-19.新型冠状病毒肺炎患者结膜和泪液中的严重急性呼吸综合征冠状病毒2及眼部症状
Vision (Basel). 2021 Oct 22;5(4):51. doi: 10.3390/vision5040051.
8
Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19?检测结膜分泌物中的 SARS-CoV-2 RNA:这是 COVID-19 的一种有价值的诊断方法吗?
J Med Virol. 2021 Jan;93(1):383-388. doi: 10.1002/jmv.26219. Epub 2020 Jul 6.
9
Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.中国武汉 535 例 COVID-19 的眼部表现和临床特征:一项横断面研究。
Acta Ophthalmol. 2020 Dec;98(8):e951-e959. doi: 10.1111/aos.14472. Epub 2020 May 18.
10
Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from Brazil.巴西 COVID-19 患者队列中 SARS-CoV-2 在眼表面的鉴定。
Exp Biol Med (Maywood). 2021 Dec;246(23):2495-2501. doi: 10.1177/15353702211024651. Epub 2021 Jul 19.

引用本文的文献

1
E3 ligase RAD18 targets phosphorylated IRF3 to terminate IFNB1 transcription.E3泛素连接酶RAD18靶向磷酸化的IRF3以终止IFNB1转录。
Nat Immunol. 2025 Sep;26(9):1581-1595. doi: 10.1038/s41590-025-02256-x. Epub 2025 Aug 29.
2
Ocular symptoms in COVID-19 patients with a history of hospitalization in the first pandemic wave in Styria, Austria.奥地利施蒂利亚州在第一波疫情大流行期间有住院史的新冠肺炎患者的眼部症状。
Front Ophthalmol (Lausanne). 2025 Feb 27;5:1540904. doi: 10.3389/fopht.2025.1540904. eCollection 2025.
3
Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染继发的眼部神经炎症反应——综述
Front Immunol. 2025 Feb 4;16:1515768. doi: 10.3389/fimmu.2025.1515768. eCollection 2025.
4
Impact of COVID-19 on Ocular Surface Health: Infection Mechanisms, Immune Modulation, and Inflammatory Responses.2019冠状病毒病对眼表健康的影响:感染机制、免疫调节及炎症反应
Viruses. 2025 Jan 6;17(1):68. doi: 10.3390/v17010068.
5
Evaluation of ocular surface temperature in post-COVID-19 patients with different degrees of fever via infrared thermal imaging.通过红外热成像评估不同发热程度的新冠康复患者的眼表温度
Sci Rep. 2025 Jan 17;15(1):2273. doi: 10.1038/s41598-025-86407-y.
6
A cross-sectional survey of ocular problems after COVID-19 infection among healthcare workers at a teaching hospital.某教学医院医护人员新冠病毒感染后眼部问题的横断面调查。
J Family Med Prim Care. 2024 Sep;13(9):3644-3646. doi: 10.4103/jfmpc.jfmpc_785_24. Epub 2024 Sep 11.
7
Could Ocular Glands Be Infected by SARS-CoV-2?眼部腺体可能会被新冠病毒感染吗?
Diseases. 2024 Jul 25;12(8):169. doi: 10.3390/diseases12080169.
8
SARS-CoV-2 positivity rates in tear secretions of inpatient COVID-positive individuals in an Indian tertiary care setting.印度一家三级医疗机构中新冠病毒检测呈阳性住院患者泪液分泌物中的新冠病毒2型阳性率。
Indian J Ophthalmol. 2025 Feb 1;73(2):273-279. doi: 10.4103/IJO.IJO_2347_23. Epub 2024 Jul 11.
9
Evaluation of dry eye disease symptomatology and mental health status among patients with different COVID-19 statuses.不同新冠病毒疾病状态患者的干眼症状学与心理健康状况评估
Int J Ophthalmol. 2024 May 18;17(5):822-830. doi: 10.18240/ijo.2024.05.05. eCollection 2024.
10
Occurrence of COVID-19 in cystic fibrosis patients: a review.囊性纤维化患者中新型冠状病毒肺炎的发生情况:一项综述
Front Microbiol. 2024 Apr 17;15:1356926. doi: 10.3389/fmicb.2024.1356926. eCollection 2024.

新型冠状病毒肺炎确诊患者中新型冠状病毒2型的眼部症状及嗜性评估。

Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19.

作者信息

Hong Nan, Yu Wangshu, Xia Jianhua, Shen Ye, Yap Maurice, Han Wei

机构信息

The Department of Ophthalmology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

School of Optometry, The Hong Kong Polytechnic University, Hong Kong, China.

出版信息

Acta Ophthalmol. 2020 Aug;98(5):e649-e655. doi: 10.1111/aos.14445. Epub 2020 Apr 26.

DOI:10.1111/aos.14445
PMID:32336042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7267628/
Abstract

PURPOSE

The SARS-CoV-2 RNA has been detected in tears and conjunctival samples from infected individuals. Conjunctivitis is also reported in a small number of cases. We evaluated ocular symptoms and ocular tropism of SARS-CoV-2 in a group of patients with COVID-19.

METHOD

Fifty-six patients infected with SARS-CoV-2 were recruited as subjects. Relevant medical histories were obtained from the electronic medical record system. Ocular history and ocular symptoms data were obtained by communicating directly with the subjects. The Ocular Surface Disease Index (OSDI) and Salisbury Eye Evaluation Questionnaire (SEEQ) were used to assess the anterior ocular surface condition before and after the onset of disease.

RESULTS

Patients classified as severe COVID-19 cases were more likely to have hypertension compared to mild cases (p = 0.035). Of the 56 subjects, thirteen patients (23%) were infected in Wuhan, 32 patients (57%) were community-infected, 10 patients (18%) were unknown origin, 1 (2%) was a physician likely infected by a confirmed patient. Three patients wore face mask with precaution when contacting the confirmed patients. Fifteen (27%) had aggravated ocular symptoms, of which 6 (11%) had prodromal ocular symptoms before disease onset. The differences in mean scores of OSDI questionnaire and SEEQ between before and after onset of COVID-19 were all significant (p < 0.05 for both).

CONCLUSIONS

Ocular symptoms are relatively common in COVID-19 disease and may appear just before the onset of respiratory symptoms. Our data provided the anecdotal evidences of transmission of SARS-CoV-2 via ocular surface.

摘要

目的

在感染个体的眼泪和结膜样本中检测到了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA。也有少数病例报告了结膜炎。我们评估了一组新型冠状病毒肺炎(COVID-19)患者的眼部症状和SARS-CoV-2的眼部嗜性。

方法

招募56例感染SARS-CoV-2的患者作为研究对象。从电子病历系统获取相关病史。通过直接与研究对象交流获取眼部病史和眼部症状数据。使用眼表疾病指数(OSDI)和索尔兹伯里眼评估问卷(SEEQ)评估疾病发作前后的眼前节表面状况。

结果

与轻症COVID-19病例相比,重症COVID-19病例更易患高血压(p = 0.035)。56名研究对象中,13例(23%)在武汉感染,32例(57%)为社区感染,10例(18%)感染源不明,1例(2%)为可能被确诊患者感染的医生。3例患者在接触确诊患者时佩戴了防护口罩。15例(27%)有眼部症状加重,其中6例(11%)在疾病发作前有前驱眼部症状。COVID-19发作前后OSDI问卷和SEEQ的平均得分差异均有统计学意义(两者p均<0.05)。

结论

眼部症状在COVID-19疾病中相对常见,可能在呼吸道症状发作前就出现。我们的数据提供了SARS-CoV-2通过眼表传播的轶事证据。